Jacobs & Co. CA Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Jacobs & Co. CA lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 12.6% during the 2nd quarter, Holdings Channel reports. The firm owned 459 shares of the healthcare conglomerate’s stock after selling 66 shares during the quarter. Jacobs & Co. CA’s holdings in UnitedHealth Group were worth $220,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Chelsea Counsel Co. purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $27,000. 25 LLC purchased a new position in UnitedHealth Group during the first quarter valued at $28,000. Cascade Investment Advisors Inc. acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $28,000. Freedom Wealth Alliance LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $31,000. Finally, Kalos Management Inc. purchased a new stake in UnitedHealth Group during the 1st quarter valued at about $34,000. 85.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on UNH. Royal Bank of Canada lowered their price target on shares of UnitedHealth Group from $592.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, July 17th. Stephens reiterated an “overweight” rating and issued a $560.00 target price on shares of UnitedHealth Group in a report on Friday, August 11th. Morgan Stanley restated an “overweight” rating and set a $587.00 target price on shares of UnitedHealth Group in a report on Friday, July 14th. Mizuho decreased their price target on shares of UnitedHealth Group from $600.00 to $549.00 in a research report on Tuesday, July 11th. Finally, Piper Sandler initiated coverage on shares of UnitedHealth Group in a research report on Thursday, May 25th. They issued an “overweight” rating and a $580.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $575.65.

Get Our Latest Stock Report on UnitedHealth Group

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Andrew Witty sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the transaction, the chief executive officer now owns 78,573 shares of the company’s stock, valued at $39,772,866.87. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH stock opened at $486.06 on Tuesday. The stock has a fifty day moving average of $492.05 and a two-hundred day moving average of $486.73. The firm has a market capitalization of $450.24 billion, a PE ratio of 21.75, a price-to-earnings-growth ratio of 1.43 and a beta of 0.66. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, beating the consensus estimate of $5.92 by $0.22. The business had revenue of $92.90 billion during the quarter, compared to analyst estimates of $90.97 billion. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The company’s revenue was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.57 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be given a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.65%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.